Goldman Sachs’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-473
Closed -$40K 6574
2021
Q2
$40K Buy
473
+145
+44% +$11K ﹤0.01% 6093
2021
Q1
$23K Buy
+328
New +$25.6K ﹤0.01% 6004
2020
Q3
Sell
-553
Closed -$25K 5574
2020
Q2
$25K Buy
+553
New +$24.9K ﹤0.01% 5117
2017
Q3
Sell
-452
Closed -$70K 6907
2017
Q2
$70K Buy
+452
New +$85.4K ﹤0.01% 6266
2015
Q1
Sell
-337
Closed -$70K 7326
2014
Q4
$70K Buy
+337
New +$72.8K ﹤0.01% 6706

Other funds holding NTBL

Goldman Sachs's NTBL Position: Q3 2021 in Review

Goldman Sachs sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q3 2021, closing a stake of 473 shares — an estimated $40K sold.

Goldman Sachs first reported a position in NTBL in Q4 2014 and held it in 5 quarters. The position peaked at $70K in Q2 2017. 28 funds tracked by Wall St. Rank hold NTBL as of Q3 2021.

  • Goldman Sachs reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 473 Notable Labs, Ltd. Ordinary Shares shares in Q3 2021, an estimated $40K.
  • Goldman Sachs first reported a position in Notable Labs, Ltd. Ordinary Shares in Q4 2014 and held it in 5 quarters.
  • Goldman Sachs's Notable Labs, Ltd. Ordinary Shares position peaked at $70K in Q2 2017.
  • 28 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.